Efforts by President Trump’s team to halt the unstoppable surge in drug prices appear to be paying off, according to several agencies and healthcare officials.
Drug maker Merck, for example, said prices dropped 1.9 percent last year.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.